# Trade Mark Journal No.2026/023 5 June 2026

## WO0000001918505 (5)

Office of origin: Denmark

Date of International Registration:10 April 2026
Date of designation in the UK: 10 April 2026

Class 5
  Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases; pharmaceutical preparations for the treatment of neurological disorders, including alcohol dependence and alzheimer's disease; pharmaceutical preparations for the treatment of psychiatric disorders, including depression and anxiety.

Novo Nordisk A/S